Literature DB >> 20417256

Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex.

E Ampuero1, F J Rubio, R Falcon, M Sandoval, G Diaz-Veliz, R E Gonzalez, N Earle, A Dagnino-Subiabre, F Aboitiz, F Orrego, U Wyneken.   

Abstract

It has been postulated that chronic administration of antidepressant drugs induces delayed structural and molecular adaptations at glutamatergic forebrain synapses that might underlie mood improvement. To gain further insight into these changes in the cerebral cortex, rats were treated with fluoxetine (flx) for 4 weeks. These animals showed decreased anxiety and learned helplessness. N-methyl-d-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptor subunit levels (NR1, NR2A, NR2B, GluR1 and GluR2) were analysed in the forebrain by both western blot of homogenates and immunohistochemistry. Both methods demonstrated an upregulation of NR2A, GluR1 and GluR2 that was especially significant in the retrosplenial granular b cortex (RSGb). However, when analysing subunit content in postsynaptic densities and synaptic membranes, we found increases of NR2A and GluR2 but not GluR1. Instead, GluR1 was augmented in a microsomal fraction containing intracellular membranes. NR1 and GluR2 were co-immunoprecipitated from postsynaptic densities and synaptic membranes. In the immunoprecipitates, NR2A was increased while GluR1 was decreased supporting a change in receptor stoichiometry. The changes of subunit levels were associated with an upregulation of dendritic spine density and of large, mushroom-type spines. These molecular and structural adaptations might be involved in neuronal network stabilization following long-term flx treatment. Copyright (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417256     DOI: 10.1016/j.neuroscience.2010.04.035

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  45 in total

Review 1.  Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants.

Authors:  Jason M Dwyer; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2013-01-04       Impact factor: 13.382

2.  GluA2 AMPA glutamate receptor subunit exhibits codon 607 Q/R RNA editing in the lens.

Authors:  Mohammed Farooq; Rajesh H Kaswala; Norman J Kleiman; Chinnaswamy Kasinathan; Peter H Frederikse
Journal:  Biochem Biophys Res Commun       Date:  2012-01-10       Impact factor: 3.575

3.  Hyperforin modulates dendritic spine morphology in hippocampal pyramidal neurons by activating Ca(2+) -permeable TRPC6 channels.

Authors:  Kristina Leuner; Wei Li; Michelle D Amaral; Stephanie Rudolph; Gaston Calfa; Anita M Schuwald; Christian Harteneck; Takafumi Inoue; Lucas Pozzo-Miller
Journal:  Hippocampus       Date:  2012-07-20       Impact factor: 3.899

4.  Nucleocytoplasmic export of HDAC5 and SIRT2 downregulation: two epigenetic mechanisms by which antidepressants enhance synaptic plasticity markers.

Authors:  I Muñoz-Cobo; M M Erburu; C Zwergel; R Cirilli; A Mai; S Valente; E Puerta; Rosa M Tordera
Journal:  Psychopharmacology (Berl)       Date:  2018-08-08       Impact factor: 4.530

Review 5.  Spine synapse remodeling in the pathophysiology and treatment of depression.

Authors:  Catharine H Duman; Ronald S Duman
Journal:  Neurosci Lett       Date:  2015-01-09       Impact factor: 3.046

6.  Constitutive activity of 5-HT2C receptors is present after incomplete spinal cord injury but is not modified after chronic SSRI or baclofen treatment.

Authors:  V M Tysseling; D A Klein; R Imhoff-Manuel; M Manuel; C J Heckman; M C Tresch
Journal:  J Neurophysiol       Date:  2017-09-06       Impact factor: 2.714

7.  Analysis of region-specific changes in gene expression upon treatment with citalopram and desipramine reveals temporal dynamics in response to antidepressant drugs at the transcriptome level.

Authors:  Magdalena Gąska; Maciej Kuśmider; Joanna Solich; Agata Faron-Górecka; Małgorzata J Krawczyk; Krzysztof Kułakowski; Marta Dziedzicka-Wasylewska
Journal:  Psychopharmacology (Berl)       Date:  2012-05-01       Impact factor: 4.530

Review 8.  Synaptic dysfunction in depression: potential therapeutic targets.

Authors:  Ronald S Duman; George K Aghajanian
Journal:  Science       Date:  2012-10-05       Impact factor: 47.728

9.  Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.

Authors:  Ronald S Duman; George K Aghajanian; Gerard Sanacora; John H Krystal
Journal:  Nat Med       Date:  2016-03       Impact factor: 53.440

10.  Management of patients with stroke: is it time to expand treatment options?

Authors:  Harold P Adams; Randolph J Nudo
Journal:  Ann Neurol       Date:  2013-08-06       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.